发明名称 |
COMBINATION THERAPIES |
摘要 |
The invention features a method of treating asthma, COPD, allergic rhinitis, and infectious rhinitis by administering a first pharmaceutical agent including one or more compounds selected from the quarternary ammonium compounds of formulae I V and a second pharmaceutical agent including one or more pharmaceutical agents selected from Adenosine A2a Receptor Agonists, D2-Dopamine Receptor Agonists, Phosphodiesterase Inhibitors (PDE's), corticosteroids, norepinephrine reuptake inhibitors, 4-hydroxy-7-[2-[2-[3- [2-phenylethoxy]- propylsulphonyllethylamino] ethyl] -1,3-benzothiazol-2(3H)-one, and pharmaceutically acceptable salts thereof, and non-quarternized antimuscarinic compounds. |
申请公布号 |
WO2004091596(A2) |
申请公布日期 |
2004.10.28 |
申请号 |
WO2004IB01170 |
申请日期 |
2004.04.05 |
申请人 |
PHARMACIA & UPJOHN COMPANY;MANNING, ROBERT, EVERETT;RICHARDS, IVAN, MICHAEL |
发明人 |
MANNING, ROBERT, EVERETT;RICHARDS, IVAN, MICHAEL |
分类号 |
A61K31/14;A61K31/195;A61K31/216;A61K31/235;A61K31/40;A61K31/4025;A61K31/445;A61K31/47;A61K31/55;A61K45/06 |
主分类号 |
A61K31/14 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|